FutraMed

FutraMed Inc. was founded in the State of Utah in 2004 for the purpose of engaging in the creation and application of technology to provide solutions for individuals with substance abuse and other physical and behavioral limitations. With the consumption of painkillers soaring throughout the world, FutraMed has developed a patented medical device that has clinical benefits which include reducing opioid consumption and dependence in the treatment of chronic pain. The technology for the device, a transcutaneous electrical cranial stimulator, is based on the work of Dr. Aim Limoge of Paris France and the Limoge Current which he developed. Limoge Current creates an analgesic effect and potentiates or enhances the treatment drug being used by the chronic pain patient. In collaboration with Dr. Limoge and his associates, our team was able to effectively replicate the Limoge Current and create a device that is simple to use, low cost, battery powered, meets regulatory requirements, and is easy to manufacture which is going through the final stages of regulatory approvals necessary to receive the CE mark in order to begin selling in Europe